share_log

Cowen & Co. Maintains Outperform on Cue Health, Lowers Price Target to $7

Cowen & Co. Maintains Outperform on Cue Health, Lowers Price Target to $7

Cowen & Co.Cue Health維持跑贏大盤,將目標價下調至7美元
Benzinga Real-time News ·  2022/11/14 09:26

Cowen & Co. analyst Charles Rhyee maintains Cue Health (NASDAQ:HLTH) with a Outperform and lowers the price target from $9 to $7.

Cowen & Co. 分析師查爾斯·萊伊維持Cue Health(納斯達克股票代碼:HLTH)的跑贏大盤,並將目標股價從9美元下調至7美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論